Daniele Zink
Institute of Bioengineering and Nanotechnology, Singapore
Biography
Daniele Zink earned her PhD from the University of Heidelberg, Germany in 1995 and completed her Habilitation (2001) at the Ludwig Maximilian University of Munich. In 2001, she was awarded funding of a Junior Group from the Volkswagen-Foundation, which she led until she moved to the Institute of Bioengineering and Nanotechnology (IBN) in Singapore in 2007. Her work on predictive in vitro models has been awarded by Merck Millipore and the US Society of Toxicology. She has won the prestigious LUSH Prize (2016, Science Category). She holds 10 patents/patent applications; is Editorial Board Member of Scientific Reports; has more than 70 peer reviewed publications and is Co-Founder and Director of the spin-off company Cellbae.
Abstract
Abstract : Accurate high-throughput prediction of human organ-specific toxicities